{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:04:24Z","timestamp":1763726664392,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jmii.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T10:25:11Z","timestamp":1366626311000},"page":"286-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Rapid onset of rhabdomyolysis after switching to a raltegravir-based antiretroviral regimen"],"prefix":"10.1016","volume":"49","author":[{"given":"Wan-Jung","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Shin-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Len","family":"Sy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Kuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Hsin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2013.02.008_bib1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/QAD.0b013e328303be40","article-title":"Severe rhabdomyolysis associated with raltegravir use","volume":"22","author":"Zembower","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2013.02.008_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/QAD.0b013e328334cc4a","article-title":"A case of rhabdomiolysis associated with raltegravir use","volume":"24","author":"Dori","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2013.02.008_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jinf.2010.04.011","article-title":"Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution","volume":"61","author":"Masia","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2013.02.008_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1258\/ijsa.2010.010246","article-title":"Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature","volume":"21","author":"Croce","year":"2010","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jmii.2013.02.008_bib5","first-page":"336","article-title":"Myalgia and creatine phosphokinase elevations in the HAART era: focus on Raltegravir","volume":"10","author":"Madeddu","year":"2011","journal-title":"HAART Correlated Pathologies"},{"key":"10.1016\/j.jmii.2013.02.008_bib6","unstructured":"U.S. Food and Drug Administration. Isentress (Raltegravir) prescribing information and package insert 2011. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022145s022lbl.pdf; 2011 [accessed 01.05.12]."},{"issue":"Suppl. 4","key":"10.1016\/j.jmii.2013.02.008_bib7","article-title":"Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study","volume":"13","author":"Madeddu","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jmii.2013.02.008_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/clpt.2009.12","article-title":"Pharmacokinetics of raltegravir in individuals with UGT1A1 polymorphisms","volume":"85","author":"Wenning","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jmii.2013.02.008_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1089\/aid.2011.0231","article-title":"Short communication: lack of correlation between UGT1A1*6, *28 genotypes, and plasma raltegravir concentrations in Japanese HIV type 1-infected patients","volume":"28","author":"Hirano","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jmii.2013.02.008_bib10","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1128\/AAC.05694-11","article-title":"Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy","volume":"56","author":"Ananworanich","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2013.02.008_bib11","first-page":"929","article-title":"Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy","volume":"95","author":"Eshun-Wilson","year":"2005","journal-title":"S Afr Med J"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118213000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118213000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:01Z","timestamp":1761657601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118213000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1684118213000340"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2013.02.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid onset of rhabdomyolysis after switching to a raltegravir-based antiretroviral regimen","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2013.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}